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We thank Dr. Cholongitas and colleagues for their comments
on our paper on the prognostic score for cirrhotic patients admit-
ted to an Intensive Care Unit (ICU) and for sharing their
experience.
Consistent with previous studies in critical care, these two
large series (our study with 377 patients and the evaluation of
Cholongitas et al. with 412 patients) showed that the prognosis
of patients with cirrhosis admitted to the ICU is more determined
by the number of organ failure (SOFA score) then by the deterio-
ration of the liver function.
In a critical situation, hyperlactatemia is mainly associated
with respiratory and cardiovascular dysfunction, both of which
may lead to systemic tissue hypoxia. In cirrhotic patients
admitted to the ICU, hyperlactatemia may reﬂect both an
increased production (overproduction due to systemic tissue
hypoxia associated with multiorgan failure) and a decreased
hepatic clearance (due to hepatic dysfunction). In our cohort, we
did not evaluate this marker because it is not included in the dif-
ferent prognostics scores studied in our paper (SAPS II, SOFA,
MELD. . .). Cholongitas et al. suggest that arterial lactate may be
a prognostic marker in patients with cirrhosis admitted to ICU.
Although, there is a lack of information in the data provided by
Cholongitas et al., it may be interesting to know whether a signif-
icant correlation between arterial lactate and SOFA score, the
presence of sepsis or the number of organ dysfunction exists. Even
though these associations dot not necessarily imply causality,they do suggest that multiple organ failure could be involved in
the development of hyperlactatemia.
With the SOFA score at admission, the severity of organ
dysfunction assessment and their change over time, the liver
function, the primary ICU diagnosis (sepsis or systemic inﬂam-
mation), and a possible candidacy for liver transplantation, the
arterial lactate may be an additional tool for the decision-making
process in the management of cirrhotic patients admitted to ICU.
But, to identify, in emergency at ICU admission, patients who
might beneﬁt from an ICU transfer and from an aggressive treat-
ment is still complex and challenging. We agree with Cholongitas
et al. that all cirrhotic patients admitted to ICU require re-assess-
ment in the days following the admission. For some cirrhotic
patients, the ICU treatment is futile and generates a signiﬁcant
cost. Consequently, as we concluded in our study, criteria consist-
ing of a combination of factors such SOFA and MELD scores,
together with the development of sepsis and/or the need for
organ support, might result in an improved predictive power over
each component alone and will provide guidance to the optimal
management of cirrhotic patients admitted to the ICU.
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